DENICE SMITH: Open Payments
NPI 1134171085 · ROCK FALLS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 13 payments from 10 companies in 2025. Trend: 2023 $209 · 2024 $81 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $87 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Organon LLC | 2 | $20 |
| Braeburn Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
| Exeltis, USA Inc. | 1 | $14 |
Products named: Auvelity, CAPLYTA, ABILIFY ASIMTUFII, NEXPLANON, BRIXADI, LYBALVI, ABILIFY MAINTENA, ZENPEP.
Industry payments across IL — which companies pay providers there.
